[Home](/)/[Resources](/resources)/Health Canada Medical Devices

CanadaMedical Devices

# Health Canada Medical Device Licence: Classes, Applications, and the MDR Process

Health Canada requires a Medical Device Licence (MDL) for all Class II, III, and IV medical devices sold in Canada under the Medical Devices Regulations (SOR/98-282). The four-class system maps risk to regulatory burden — from a simple Class II application to a full clinical evidence package for Class IV. Understanding where your device sits in that system is the first and most consequential decision in your Canadian regulatory strategy.

Copy Link[Share on WhatsApp](https://wa.me/?text=https%3A%2F%2Fkrono-labs.com%2Fguides%2Fcanada-health-canada-medical-devices)

At a glance

Regulator

Health Canada (Medical Devices Bureau)

Framework

Medical Devices Regulations (SOR/98-282)

Licence required

Class II, III, IV

Class I

Establishment Licence only

## Canada's medical device classification and licensing framework

### Canada's four-class medical device system

Class I covers the lowest-risk devices — tongue depressors, bandages, non-sterile surgical gloves. Class I manufacturers require only an Establishment Licence (EL), not an MDL. Class II covers moderate-risk devices including contact lenses, pregnancy tests, and non-implantable diagnostic equipment — an MDL is required. Class III covers higher-risk devices such as orthopedic implants and haemodialysis machines. Class IV covers the highest-risk devices including pacemakers, heart valves, and certain in vitro diagnostics for life-threatening conditions. Classes III and IV require an MDL with substantially more rigorous clinical evidence.

### Medical Device Licence application requirements

The MDL application is submitted to Health Canada through the Medical Devices Electronic Submissions Gateway (MDALL). Applications must include: device description and intended use, classification justification, a list of applicable standards used in design and testing, performance and safety testing data summary, ISO 13485 quality management system certificate, labeling in both English and French, and the applicable application fee. Class III and IV applications additionally require a summary of clinical evidence demonstrating safety and effectiveness for the intended use.

### ISO 13485 and MDSAP requirements

Class II, III, and IV MDL applicants must hold a current ISO 13485 quality management system certificate from an accredited certification body. Health Canada strongly prefers — and for practical purposes expects — ISO 13485 certificates issued under the Medical Device Single Audit Program (MDSAP). An MDSAP audit covers Health Canada requirements alongside FDA, EU MDR, TGA (Australia), ANVISA (Brazil), and PMDA (Japan) requirements in a single audit cycle, eliminating the need for separate national QMS audits for manufacturers selling across multiple markets.

### International regulatory reliance and the Access Consortium

Health Canada participates in the Access Consortium — a collaboration with regulatory authorities in Australia, Singapore, Switzerland, the UK, and the EU (via the European Medicines Agency for borderline products). Health Canada can use regulatory decisions and review work from Access Consortium partners when assessing MDL applications, reducing duplication for devices already approved in comparable markets. This is particularly relevant for Class III and IV devices with existing FDA PMA approval or EU MDR certification under a Notified Body.

## MDL application process step by step

01

Classify your medical device using the classification rules in Schedule 1 of Canada's Medical Devices Regulations (SOR/98-282). Classification is based on intended use, risk level, duration of contact with the patient, and whether the device is implantable, active, or in vitro diagnostic. For novel or combination products, engage a Canadian regulatory consultant — Health Canada publishes guidance documents on specific device types, but classification disputes can significantly delay MDL review.

02

Obtain ISO 13485 certification from an MDSAP-accepted auditing organisation. MDSAP is Health Canada's preferred audit program and substantially streamlines ongoing QMS oversight across multiple markets. Accepted MDSAP auditing organisations include BSI, SGS, TÜV SÜD, Dekra, and others listed on the IMDRF MDSAP website. Build QMS certification time into your project plan — initial MDSAP audit and certification typically takes 6 to 9 months from program enrollment.

03

Prepare the MDL application package appropriate for your device class. Class II applications require device description, intended use statement, applicable standards list, performance testing summary, ISO 13485 or MDSAP certificate, English and French labels, and the current Class II application fee. Class III and IV applications require all of the above plus a clinical evidence summary, a benefit-risk analysis, and additional manufacturing and sterilisation information where applicable.

04

Submit the application via the MDALL electronic gateway and respond promptly to any screening queries from Health Canada's Medical Devices Bureau. Screening ensures the application is administratively complete before technical review begins. Health Canada's target review timelines are 75 days for Class II, 300 days for Class III, and 300 days for Class IV. These timelines run from screening acceptance, not application submission.

05

After MDL issuance, maintain post-market obligations under the Medical Devices Regulations. File Mandatory Problem Reports (MPRs) within 10 days for incidents involving serious deterioration in health or a death linked to your device. Maintain distribution records sufficient to support a targeted recall. Notify Health Canada of significant device changes — changes that affect intended use, safety, or effectiveness require a licence amendment before the changed device is sold in Canada.

## Frequently asked questions

### Does FDA 510(k) clearance help with Health Canada MDL applications?

Yes, meaningfully so. Health Canada participates in international reliance programs and the Access Consortium, and actively uses FDA review work as supporting evidence for Class III and IV MDL applications. For Class II devices, FDA 510(k) clearance is not directly cited in the MDL application but demonstrates the device has passed a comparable substantial equivalence assessment. The MDL application still requires Canada-specific content — English and French labeling, a Canadian standards reference list, and fee payment — regardless of FDA clearance status. Health Canada has also entered bilateral arrangements with the FDA to share information on specific high-priority device types.

### What is MDSAP and why does Health Canada prefer it over standalone ISO 13485?

The Medical Device Single Audit Program (MDSAP) is an international program that allows a single quality management system audit to satisfy the requirements of multiple regulatory authorities simultaneously. MDSAP participating regulators include Health Canada, the US FDA, Australia's TGA, Brazil's ANVISA, and Japan's PMDA. An MDSAP certificate covers all of their QMS requirements in one audit cycle. Health Canada accepts MDSAP certificates as evidence of ISO 13485 compliance and increasingly treats MDSAP participation as the expected standard for MDL applicants. Standalone ISO 13485 certificates (from non-MDSAP auditing organisations) are accepted but require additional scrutiny and may delay screening acceptance.

### How long does Health Canada MDL review take for Class II devices?

Health Canada's published target review timeline for Class II MDL applications is 75 days from the date the application passes administrative screening. Screening itself typically takes 10 to 15 business days after submission. If Health Canada raises questions during technical review (a Request for Information, or RFI), the clock pauses while the manufacturer responds, extending the effective timeline. Plan for a total timeline of 4 to 6 months from submission to MDL issuance for well-prepared Class II applications, accounting for potential screening and technical review questions.

### Do both English and French labels need to be submitted?

Yes. Canada's Official Languages Act requires that consumer product labeling — including medical device labeling — be provided in both English and French. The MDL application must include labeling in both official languages. Health Canada reviews both language versions for accuracy and completeness. Labels that are English-only will not pass screening. For clinical and IFU documents submitted as part of the technical application package, English is accepted for the technical review; the bilingual labeling requirement applies specifically to the labels and instructions that accompany the device when sold to Canadian end users.

**Disclaimer:** Educational resource only. Regulatory requirements change and vary by product category. Consult an accredited test laboratory or qualified compliance engineer before making certification decisions.

🇨🇦 Canada roadmap for your product

Every standard, document, and test that applies — free, no account required.

See your free roadmap[

Want an expert to take your product through 🇨🇦 Canada compliance for you?

One consultant from Krono's compliance team takes your product from requirements to legal sale, with a fixed quote before any work starts.

See compliance services](/services)

Learn this properly

In-depth course that teaches the full process, not just this one answer.

[Start the course — $199](/courses/43-canada-health-canada-medical-device-licensing-class-ii-iv)[Prefer to read? Get the book — $24.99](/books/43-canada-health-canada-medical-device-licensing-class-ii-iv)

Related guides

*   [Canada ISED Radio CertificationCanada ISED radio equipment certification: RSS standards, accredited CB scheme test reports, IC ID number, and the Spectrum Direct online certification portal.](/guides/canada-ised-radio-certification)
*   [Canada CPSACanada Consumer Product Safety Act (CCPSA): prohibited products, mandatory incident reporting within 10 days, recall authority, and administrative monetary penalties for non-compliance.](/guides/canada-consumer-product-safety-act)
*   [Australia TGA Class I DevicesAustralia TGA Class I medical devices: ARTG inclusion by sponsor, Essential Principles self-assessment, ISO 13485 QMS expectations, and post-market adverse event reporting.](/guides/australia-tga-class-i-devices)
*   [India CDSCO Medical DevicesIndia CDSCO medical device registration: Class A–D risk classification, CDSD application for Class B–D, BIS/ISO standards, and the 2024 amendment to the Medical Devices Rules.](/guides/india-cdsco-medical-devices)